Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Tiia Kettunen"'
Autor:
Satu Tiainen, Veera Nurmela, Tuomas Selander, Patrik Turunen, Sanna Pasonen-Seppänen, Tiia Kettunen, Outi Kuittinen, Päivi Auvinen, Aino Rönkä
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-11 (2023)
Abstract Background Less than half of unselected metastatic cancer patients benefit from the immune checkpoint inhibitor (ICI) therapy. Systemic cancer-related inflammation may influence the efficacy of ICIs and thus, systemic inflammatory markers co
Externí odkaz:
https://doaj.org/article/a71c5c394cf14b87af8b8c75425ea68e
Autor:
Hidemi Okuma, Mazen Sudah, Tiia Kettunen, Anton Niukkanen, Anna Sutela, Amro Masarwah, Veli-Matti Kosma, Päivi Auvinen, Arto Mannermaa, Ritva Vanninen
Publikováno v:
PLoS ONE, Vol 15, Iss 6, p e0235278 (2020)
PurposeThe apparent diffusion coefficient (ADC) is increasingly used to characterize breast cancer. The peritumor/tumor ADC ratio is suggested to be a reliable and generally applicable index. However, its overall prognostication value remains unclear
Externí odkaz:
https://doaj.org/article/82fd656d4144432da6f0bb6fcc2800d0
Autor:
Hannes Vihinen, Artturi Jokinen, Teemu D. Laajala, Nesna Wahid, Lotta Peltola, Tiia Kettunen, Aino Rönkä, Leena Tiainen, Tanja Skyttä, Laura Kohtamäki, Sanni Tulokas, Hanna Karhapää, Micaela Hernberg, Maria Silvoniemi, Kalle E. Mattila
Background: Antibiotic treatment may reduce the efficacy of cancer immunotherapy by disrupting gut microbiome. We aimed to study the association of antibiotics and survival outcomes in advanced cutaneous melanoma and non–small-cell lung cancer (NSC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b9397807726ec00b5d416db90d48111
https://trepo.tuni.fi/handle/10024/149362
https://trepo.tuni.fi/handle/10024/149362
Autor:
Ritva Vanninen, Anna Sutela, Sanna Oikari, Satu Tiainen, Mazen Sudah, Raija Tammi, Tiia Kettunen, Hidemi Okuma, Amro Masarwah, Markku Tammi, Päivi Auvinen
Publikováno v:
European Radiology
Objectives We aimed to evaluate the differences in peritumoral apparent diffusion coefficient (ADC) values by four different ROI selection methods and to validate the optimal method. Furthermore, we aimed to evaluate if the peritumor-tumor ADC ratios
Autor:
Tiia Kettunen, Hidemi Okuma, Mazen Sudah, Päivi Auvinen, Veli-Matti Kosma, Anna Sutela, Anton Niukkanen, Ritva Vanninen, Amro Masarwah, Arto Mannermaa
Publikováno v:
PLoS ONE
PLoS ONE, Vol 15, Iss 6, p e0235278 (2020)
PLoS ONE, Vol 15, Iss 6, p e0235278 (2020)
PurposeThe apparent diffusion coefficient (ADC) is increasingly used to characterize breast cancer. The peritumor/tumor ADC ratio is suggested to be a reliable and generally applicable index. However, its overall prognostication value remains unclear
Autor:
Satu Tiainen, Mazen Sudah, Ritva Vanninen, Jukka Häyrinen, Tiia Kettunen, Markku Tammi, Sanna Oikari, Anna Sutela, Päivi Auvinen, Amro Masarwah
Publikováno v:
Matrix biology : journal of the International Society for Matrix Biology. 67
Increased uptake of glucose, a general hallmark of malignant tumors, leads to an accumulation of intermediate metabolites of glycolysis. We investigated whether the high supply of these intermediates promotes their flow into UDP-sugars, and consequen
Autor:
Markku Tammi, Amro Masarwah, Sanna Oikari, Tiia Kettunen, Satu Tiainen, Päivi Auvinen, Ritva Vanninen
Publikováno v:
Cancer Research. 76:39-39
A common feature to most cancers is their disturbed glucose metabolism: increased glucose and glutamine uptake combined with preference to utilize aerobic glycolysis, a phenomenon called Warburg effect. In addition to providing fast, yet inefficient